$MNKD
MANNKIND CORP

2013 Q3 Form 10-Q Financial Statement

#000119312513329193 Filed on August 09, 2013

View on sec.gov

Income Statement

Concept 2013 Q3 2013 Q2 2012 Q2
Revenue $0.00 $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $17.50M $14.50M $9.700M
YoY Change 90.22% 49.48% 8.99%
% of Gross Profit
Research & Development $27.28M $27.05M $26.64M
YoY Change 7.18% 1.55% -12.09%
% of Gross Profit
Depreciation & Amortization $2.874M $2.956M $3.304M
YoY Change -11.21% -10.53% -15.28%
% of Gross Profit
Operating Expenses $44.76M $41.59M $44.05M
YoY Change 26.01% -5.6% 12.38%
Operating Profit -$44.76M -$41.59M -$44.05M
YoY Change 26.14% -5.6%
Interest Expense -$6.100M -$4.600M -$5.900M
YoY Change 19.61% -22.03% 11.32%
% of Operating Profit
Other Income/Expense, Net $10.00K $15.00K $13.35M
YoY Change -100.38% -99.89%
Pretax Income -$50.82M -$46.12M -$36.58M
YoY Change 17.52% 26.1% -17.8%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$50.82M -$46.12M -$36.58M
YoY Change 18.64% 26.1% -17.77%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$856.7K -$811.6K -$1.144M
COMMON SHARES
Basic Shares Outstanding 301.8M shares 290.9M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q3 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $93.80M $28.50M $32.00M
YoY Change 4366.67% -10.94% 26.48%
Cash & Equivalents $93.80M $28.53M $31.64M
Short-Term Investments $25.90M $400.0K
Other Short-Term Assets $5.200M $3.200M $18.40M
YoY Change -75.36% -82.61% 1050.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $99.33M $32.16M $50.30M
YoY Change 328.14% -36.06% 86.99%
LONG-TERM ASSETS
Property, Plant & Equipment $177.8M $179.6M $189.2M
YoY Change -4.7% -5.09% -5.59%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.23M $230.0K $900.0K
YoY Change 1945.4% -74.44% -18.18%
Total Long-Term Assets $188.3M $180.3M $190.1M
YoY Change 0.63% -5.17% -5.66%
TOTAL ASSETS
Total Short-Term Assets $99.33M $32.16M $50.30M
Total Long-Term Assets $188.3M $180.3M $190.1M
Total Assets $287.6M $212.4M $240.4M
YoY Change 36.76% -11.64% 5.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.786M $5.419M $5.800M
YoY Change 143.31% -6.57% 262.5%
Accrued Expenses $21.55M $26.98M $40.90M
YoY Change -54.24% -34.02% 180.14%
Deferred Revenue
YoY Change
Short-Term Debt $72.90M $119.6M $0.00
YoY Change
Long-Term Debt Due $114.9M $114.7M
YoY Change
Total Short-Term Liabilities $217.2M $266.8M $55.40M
YoY Change 319.25% 381.56% 156.48%
LONG-TERM LIABILITIES
Long-Term Debt $217.9M $98.00M $429.3M
YoY Change -49.89% -77.17% -5.06%
Other Long-Term Liabilities $20.31M
YoY Change
Total Long-Term Liabilities $20.31M $98.00M $429.3M
YoY Change -95.33% -77.17% -5.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $217.2M $266.8M $55.40M
Total Long-Term Liabilities $20.31M $98.00M $429.3M
Total Liabilities $455.3M $364.8M $484.8M
YoY Change -6.43% -24.76% 2.34%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $2.075B $2.040B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$167.7M -$152.4M -$244.4M
YoY Change
Total Liabilities & Shareholders Equity $287.6M $212.4M $240.4M
YoY Change 36.76% -11.64% 5.25%

Cashflow Statement

Concept 2013 Q3 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income -$50.82M -$46.12M -$36.58M
YoY Change 18.64% 26.1% -17.77%
Depreciation, Depletion And Amortization $2.874M $2.956M $3.304M
YoY Change -11.21% -10.53% -15.28%
Cash From Operating Activities -$32.91M -$29.74M -$25.01M
YoY Change -3.94% 18.91% -31.95%
INVESTING ACTIVITIES
Capital Expenditures -$230.0K -$130.0K -$130.0K
YoY Change 91.67% 0.0% -96.84%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $40.00K
YoY Change -100.0% -33.33%
Cash From Investing Activities -$230.0K -$130.0K -$90.00K
YoY Change 91.67% 44.44% -97.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 98.42M 30.40M 390.0K
YoY Change 2082.26% 7694.87% -97.91%
NET CHANGE
Cash From Operating Activities -32.91M -29.74M -25.01M
Cash From Investing Activities -230.0K -130.0K -90.00K
Cash From Financing Activities 98.42M 30.40M 390.0K
Net Change In Cash 65.28M 530.0K -24.71M
YoY Change -318.55% -102.14% 11.51%
FREE CASH FLOW
Cash From Operating Activities -$32.91M -$29.74M -$25.01M
Capital Expenditures -$230.0K -$130.0K -$130.0K
Free Cash Flow -$32.68M -$29.61M -$24.88M
YoY Change -4.28% 19.01% -23.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31250000 shares
CY2012Q1 mnkd Units Sold Warrant Portion Convertible Into Common Stock
UnitsSoldWarrantPortionConvertibleIntoCommonStock
0.6
CY2012Q1 mnkd Issuance Of Common Stock And Warrants Gross Value
IssuanceOfCommonStockAndWarrantsGrossValue
86300000
CY2012Q1 mnkd Units Sold Under Public Offer Underwritten
UnitsSoldUnderPublicOfferUnderwritten
35937500 shares
CY2012Q1 mnkd Restricted Stock Agreed To Be Purchased By Lender
RestrictedStockAgreedToBePurchasedByLender
77200000
CY2012Q2 mnkd Fair Value Input Discount For Lack Of Marketability
FairValueInputDiscountForLackOfMarketability
0.0167 pure
CY2012Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
2.60
CY2012Q4 mnkd Warrants Expiration Month And Year
WarrantsExpirationMonthAndYear
2013-10
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
301774215 shares
CY2012Q1 mnkd Increase Decrease In Fair Value Recognized In Other Income
IncreaseDecreaseInFairValueRecognizedInOtherIncome
-336000
CY2012Q1 mnkd Fair Value Input Discount For Lack Of Marketability
FairValueInputDiscountForLackOfMarketability
0.0164 pure
CY2012Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31250000 shares
CY2012Q2 us-gaap Ownshare Lending Arrangement Shares Issued
OwnshareLendingArrangementSharesIssued
9000000 shares
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31639000
CY2012Q2 mnkd Increase Decrease In Fair Value Recognized In Other Income
IncreaseDecreaseInFairValueRecognizedInOtherIncome
12000000
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
300869683 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q2 us-gaap Ownshare Lending Arrangement Shares Outstanding
OwnshareLendingArrangementSharesOutstanding
9000000 shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
300869683 shares
CY2013Q2 us-gaap Ownshare Lending Arrangement Shares Issued
OwnshareLendingArrangementSharesIssued
9000000 shares
CY2013Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
212748000
CY2013Q2 us-gaap Interest Payable Current
InterestPayableCurrent
7911000
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
266782000
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8000
CY2013Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8146000
CY2013Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
107039000
CY2013Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1708000
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5419000
CY2013Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
119635000
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
-152357000
CY2013Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2036640000
CY2013Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
64600000
CY2013Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
125400000
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26984000
CY2013Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
98004000
CY2013Q2 us-gaap Liabilities
Liabilities
364786000
CY2013Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
114744000
CY2013Q2 us-gaap Construction Payable Current
ConstructionPayableCurrent
2661000
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
3012000
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
212429000
CY2013Q2 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
119600000
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
230000
CY2013Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
286606000
CY2013Q2 us-gaap Nontrade Receivables Noncurrent
NontradeReceivablesNoncurrent
470000
CY2013Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
28500000
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
179567000
CY2013Q2 us-gaap Assets
Assets
212429000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28529000
CY2013Q2 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
450000
CY2013Q2 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
2192001000
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3183000
CY2013Q2 us-gaap Assets Current
AssetsCurrent
32162000
CY2013Q2 mnkd Warrants Expiration Month And Year
WarrantsExpirationMonthAndYear
2013-10
CY2013Q2 mnkd Accrued Research And Clinical Trial Costs
AccruedResearchAndClinicalTrialCosts
6558000
CY2013Q2 mnkd Preferred Stock Shares Undesignated
PreferredStockSharesUndesignated
10000000 shares
CY2013Q2 mnkd Available Borrowings Under Loan Agreement
AvailableBorrowingsUnderLoanAgreement
125400000
CY2013Q2 mnkd Estimated Amounts Credit Exchange Receivable
EstimatedAmountsCreditExchangeReceivable
470000
CY2013Q2 mnkd Prepaid And Other Current Assets Under Credit Exchange Program
PrepaidAndOtherCurrentAssetsUnderCreditExchangeProgram
450000
CY2013Q2 mnkd Common Stock Loaned Under Share Lending Agreement Shares
CommonStockLoanedUnderShareLendingAgreementShares
9000000 shares
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2681000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
286035082 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
286035082 shares
CY2012Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
212026000
CY2012Q4 us-gaap Interest Payable Current
InterestPayableCurrent
4533000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
144775000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6000
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10074000
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
101249000
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1297000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4555000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-110679000
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1991379000
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
25777000
CY2012Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
97583000
CY2012Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
119635000
CY2012Q4 us-gaap Liabilities
Liabilities
361993000
CY2012Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
114443000
CY2012Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
3878000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
2860000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
251314000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
230000
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
285210000
CY2012Q4 us-gaap Nontrade Receivables Noncurrent
NontradeReceivablesNoncurrent
313000
CY2012Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
61800000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
183961000
CY2012Q4 us-gaap Assets
Assets
251314000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61840000
CY2012Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
450000
CY2012Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
2104912000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4520000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
66810000
CY2012Q4 mnkd Accrued Research And Clinical Trial Costs
AccruedResearchAndClinicalTrialCosts
5995000
CY2012Q4 mnkd Estimated Amounts Credit Exchange Receivable
EstimatedAmountsCreditExchangeReceivable
313000
CY2012Q4 mnkd Prepaid And Other Current Assets Under Credit Exchange Program
PrepaidAndOtherCurrentAssetsUnderCreditExchangeProgram
450000
CY2012Q4 mnkd Common Stock Loaned Under Share Lending Agreement Shares
CommonStockLoanedUnderShareLendingAgreementShares
9000000 shares
dei Trading Symbol
TradingSymbol
MNKD
dei Entity Registrant Name
EntityRegistrantName
MANNKIND CORP
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Entity Central Index Key
EntityCentralIndexKey
0000899460
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2014-01-01
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-61771000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1337000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-87089000
us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
4605000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
129432728 shares
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P9M18D
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1591000
us-gaap Investment Income Interest
InvestmentIncomeInterest
2000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-87089000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
38000
us-gaap Interest Paid
InterestPaid
5006000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-87091000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2000
us-gaap Operating Income Loss
OperatingIncomeLoss
-78022000
us-gaap Net Income Loss
NetIncomeLoss
-87089000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2398000
mnkd Nominal Lending Fee
NominalLendingFee
0.01
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-2000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24572000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
722000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30051000
us-gaap Share Based Compensation
ShareBasedCompensation
15362000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6668000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-33311000
us-gaap Interest Expense Debt
InterestExpenseDebt
5729000
us-gaap Operating Expenses
OperatingExpenses
78022000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
28308000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-974000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
53450000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5946000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15362000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1591000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
3378000
mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
282062000 shares
mnkd Amortization Period Of Lease Hold Improvements
AmortizationPeriodOfLeaseHoldImprovements
P4Y
mnkd Gain Loss On Sale Abandonment Disposal Or Impairment Of Property And Equipment
GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment
-686000
us-gaap Share Based Compensation
ShareBasedCompensation
5951000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
7343000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27193000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
682000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
86837000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
53000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
11876000
mnkd Payment Of Employment Taxes Related To Vested Restricted Stock Units
PaymentOfEmploymentTaxesRelatedToVestedRestrictedStockUnits
448000
mnkd Estimated Public Offering Gross Proceeds
EstimatedPublicOfferingGrossProceeds
89700000
mnkd Percentage Of Credit Exchange Receivable
PercentageOfCreditExchangeReceivable
0.65 pure
mnkd Related Party Transaction Prepayment Period
RelatedPartyTransactionPrepaymentPeriod
P90D
mnkd Maturity Period Of Cash Equivalents
MaturityPeriodOfCashEquivalents
90 days or less at the time of purchase
mnkd Proceeds From Exercise Of Warrants
ProceedsFromExerciseOfWarrants
25100000
mnkd State Research And Development Credit Exchange Receivable
StateResearchAndDevelopmentCreditExchangeReceivable
-157000
mnkd Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
80600000
mnkd Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
2191000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-57504000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
61741900 shares
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.49
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
448000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
12011000
us-gaap Investment Income Interest
InvestmentIncomeInterest
2000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-74751000
us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
2343000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14729000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
48000
us-gaap Interest Paid
InterestPaid
4751000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-74751000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
15731000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-74698000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2716000
us-gaap Operating Income Loss
OperatingIncomeLoss
-77987000
us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
-117000
us-gaap Net Income Loss
NetIncomeLoss
-74751000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
5000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1244000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
73000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
50794000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6661000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
28958000
us-gaap Interest Expense Debt
InterestExpenseDebt
5419000
us-gaap Operating Expenses
OperatingExpenses
77987000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
6250000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5951000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-375000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-48000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
6076000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
33308000
mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
151506000 shares
mnkd Gain Loss On Sale Abandonment Disposal Or Impairment Of Property And Equipment
GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment
73000
mnkd Payment Of Employment Taxes Related To Vested Restricted Stock Units
PaymentOfEmploymentTaxesRelatedToVestedRestrictedStockUnits
405000
mnkd Cancellation Of Principal On Note Payable To Related Party
CancellationOfPrincipalOnNotePayableToRelatedParty
77187000
mnkd State Research And Development Credit Exchange Receivable
StateResearchAndDevelopmentCreditExchangeReceivable
-185000
mnkd Reclassification Of Forward Purchase Contract To Additional Paid In Capital
ReclassificationOfForwardPurchaseContractToAdditionalPaidInCapital
13091000
mnkd Forward Purchase Contract Contribution To Additional Paid In Capital
ForwardPurchaseContractContributionToAdditionalPaidInCapital
1080000
mnkd Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
80992000
CY2007Q4 mnkd Loan Agreement With Related Party
LoanAgreementWithRelatedParty
350000000
CY2012Q1 mnkd Warrant Expiration Month Year
WarrantExpirationMonthYear
2016-02
CY2012Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
46000000 shares
CY2012Q4 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
92000000
CY2012Q4 mnkd Warrant Or Right Expiration Term
WarrantOrRightExpirationTerm
Fourth quarter of 2013
CY2012Q4 mnkd Net Proceeds From Public Offering
NetProceedsFromPublicOffering
86300000
CY2012Q4 mnkd Number Of Shares Of Common Stock In Each Unit
NumberOfSharesOfCommonStockInEachUnit
1 shares
CY2012Q4 mnkd Common Stock Issuable Upon Exercise Of Warrants Conversion Ratio
CommonStockIssuableUponExerciseOfWarrantsConversionRatio
0.75 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1658032000
us-gaap Sales Revenue Net
SalesRevenueNet
3166000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
329337000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1237000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
48000
us-gaap Income Taxes Paid
IncomeTaxesPaid
26000
us-gaap Investment Income Interest
InvestmentIncomeInterest
36998000
us-gaap Stock Issued1
StockIssued1
2758000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
230000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
796779000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2215213000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1667000
us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
4605000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2229000
us-gaap Interest Paid
InterestPaid
64158000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2192383000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1233000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2192009000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1097000
us-gaap Operating Income Loss
OperatingIncomeLoss
-2139287000
us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
-990000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
70000000
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-6494000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1028000
us-gaap Net Income Loss
NetIncomeLoss
-2192001000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-8000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
3331000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
14219000
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
5248000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3460000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
450276000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2015830000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
952000
us-gaap Share Based Compensation
ShareBasedCompensation
153280000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
133445000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
28529000
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
15000000
us-gaap Interest Expense Debt
InterestExpenseDebt
45662000
us-gaap Operating Expenses
OperatingExpenses
2142453000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
207050000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-382000
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
1742000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
28308000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3444000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3900000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
454000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1521023000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
4220000
us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
22260000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
387750000
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
19726000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
151428000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
796393000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-329269000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
48000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
42203000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
37447000
mnkd Collection Of Convertible Preferred Stock Subscriptions Receivable
CollectionOfConvertiblePreferredStockSubscriptionsReceivable
50000000
mnkd Accrued Interest On Investments Net Of Amortization Of Discounts
AccruedInterestOnInvestmentsNetOfAmortizationOfDiscounts
191000
mnkd Gain Loss On Sale Abandonment Disposal Or Impairment Of Property And Equipment
GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment
-24939000
mnkd Payment Of Employment Taxes Related To Vested Restricted Stock Units
PaymentOfEmploymentTaxesRelatedToVestedRestrictedStockUnits
13475000
mnkd Issuance Of Put Option By Stockholder
IssuanceOfPutOptionByStockholder
2949000
mnkd Put Option Redemption By Stockholder
PutOptionRedemptionByStockholder
1921000
mnkd Stock Expense For Shares Issued Pursuant To Research Agreement
StockExpenseForSharesIssuedPursuantToResearchAgreement
3018000
mnkd Put Shares Sold To Majority Stockholder
PutSharesSoldToMajorityStockholder
623000
mnkd Cancellation Of Principal On Note Payable To Related Party
CancellationOfPrincipalOnNotePayableToRelatedParty
212334000
mnkd Issuance Of Redeemable Convertible Preferred Stock
IssuanceOfRedeemableConvertiblePreferredStock
4296000
mnkd State Research And Development Credit Exchange Receivable
StateResearchAndDevelopmentCreditExchangeReceivable
-920000
mnkd Reclassification Of Forward Purchase Contract To Additional Paid In Capital
ReclassificationOfForwardPurchaseContractToAdditionalPaidInCapital
28080000
mnkd Forward Purchase Contract Contribution To Additional Paid In Capital
ForwardPurchaseContractContributionToAdditionalPaidInCapital
29317000
mnkd Increase In Additional Paid In Capital Resulting From Merger
IncreaseInAdditionalPaidInCapitalResultingFromMerger
171154000
CY2013Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2956000
CY2012Q2 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
159859000 shares
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2013Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-46124000
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10172000
CY2013Q2 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
1689000
CY2013Q2 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
284044000 shares
mnkd Issuance Of Convertible Preferred Stock Subscriptions
IssuanceOfConvertiblePreferredStockSubscriptions
50000000
mnkd Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
1399947000
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2012Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-36578000
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13347000
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-36578000
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-36572000
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-44054000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-36578000
CY2012Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
6000
CY2012Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6000
CY2012Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17416000
CY2012Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
343000
CY2012Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
2844000
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
44054000
CY2012Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
26638000
CY2012Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3304000
CY2012Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3072000
CY2012Q2 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
3028000
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-46124000
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-46124000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-41585000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-46124000
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14533000
CY2013Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
364000
CY2013Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
2866000
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
41585000
CY2013Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
27052000

Files In Submission

Name View Source Status
0001193125-13-329193-index-headers.html Edgar Link pending
0001193125-13-329193-index.html Edgar Link pending
0001193125-13-329193.txt Edgar Link pending
0001193125-13-329193-xbrl.zip Edgar Link pending
d548303d10q.htm Edgar Link pending
d548303dex101.htm Edgar Link pending
d548303dex311.htm Edgar Link pending
d548303dex312.htm Edgar Link pending
d548303dex32.htm Edgar Link pending
d548303dex991.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
g548303g10z47.jpg Edgar Link pending
mnkd-20130630.xml Edgar Link completed
mnkd-20130630.xsd Edgar Link pending
mnkd-20130630_cal.xml Edgar Link unprocessable
mnkd-20130630_def.xml Edgar Link unprocessable
mnkd-20130630_lab.xml Edgar Link unprocessable
mnkd-20130630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R40.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R41.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R42.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending